Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 22Unknown 13Recruiting 9Terminated 7Withdrawn 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Pelvic Mass 1Neoplasms 1Hemorrhage 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Tranexamic Acid × Clear all
NCT03128866 2026-03-05

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
80 enrolled

Pelvic Mass

NCT02261415 2022-10-26

HeLiX

Sunnybrook Health Sciences Centre

Phase 3 Active not recruiting
1,386 enrolled

Hemorrhage, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡